Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer|Operable Breast Cancer
Interventions: DRUG: Trastuzumab + Paclitaxel|DRUG: Pegfilgrastim
Sponsor: Centre Leon Berard
Collaborators: Amgen